CIK: 0001595851 · Show all filings
Period: Q2 2015 (← Previous) (Next →)
Filing Date: Sep 9, 2015
Total Value: $309M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALLERGAN PLC | 45,000 | $13.66M | 4.4% | $303.47 | — | SHS | G0177J108 |
| — | FLAMEL TECHNOLOGIES SA | 575,000 | $12.18M | 3.9% | $19.78 | — | SPONSORED ADR | 338488109 |
| BIIB | BIOGEN INC | 30,000 | $12.12M | 3.9% | $401.33 | 0.0% | COM | 09062X103 |
| — | NUVASIVE INC | 235,000 | $11.13M | 3.6% | $44.27 | — | COM | 670704105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 90,000 | $10.79M | 3.5% | $98.18 | +21.7% | COM | 02043Q107 |
| — | FIVE PRIME THERAPEUTICS INC | 425,000 | $10.56M | 3.4% | $24.37 | — | COM | 33830X104 |
| ISRG | INTUITIVE SURGICAL INC | 20,000 | $9.69M | 3.1% | $55.94 | 0.0% | COM NEW | 46120E602 |
| — | ENDO INTL PLC | 120,000 | $9.558M | 3.1% | $79.65 | — | SHS | G30401106 |
| — | GW PHARMACEUTICALS PLC | 75,000 | $9.213M | 3.0% | $103.82 | — | ADS | 36197T103 |
| — | ALEXION PHARMACEUTICALS INC | 50,000 | $9.039M | 2.9% | $180.78 | — | COM | 015351109 |
| — | PORTOLA PHARMACEUTICALS INC | 170,000 | $7.744M | 2.5% | $27.98 | — | COM | 737010108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 60,000 | $7.409M | 2.4% | $125.98 | 0.0% | COM | 92532F100 |
| — | HORIZON PHARMA PLC | 200,000 | $6.948M | 2.3% | $34.74 | — | SHS | G4617B105 |
| — | GENMARK DIAGNOSTICS INC | 750,000 | $6.795M | 2.2% | $9.06 | — | COM | 372309104 |
| — | NANOSTRING TECHNOLOGIES INC | 400,000 | $6.168M | 2.0% | $12.91 | — | COM | 63009R109 |
| ESPR | ESPERION THERAPEUTICS INC NE | 75,000 | $6.132M | 2.0% | $97.89 | 0.0% | COM | 29664W105 |
| — | CEPHEID | 100,000 | $6.115M | 2.0% | $55.89 | — | COM | 15670R107 |
| — | CIGNA CORPORATION | 37,500 | $6.075M | 2.0% | $162.00 | — | COM | 125509109 |
| — | EPIZYME INC | 250,000 | $6M | 1.9% | $21.60 | — | COM | 29428V104 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 122,500 | $5.851M | 1.9% | $42.40 | 0.0% | COM | 64125C109 |
| FOLD | AMICUS THERAPEUTICS INC | 375,000 | $5.306M | 1.7% | $7.47 | +61.0% | COM | 03152W109 |
| — | ATARA BIOTHERAPEUTICS INC | 100,000 | $5.276M | 1.7% | $52.76 | — | COM | 046513107 |
| DXCM | DEXCOM INC | 65,000 | $5.199M | 1.7% | $17.56 | 0.0% | COM | 252131107 |
| — | AETNA INC NEW | 40,000 | $5.098M | 1.7% | $127.45 | — | COM | 00817Y108 |
| — | ANACOR PHARMACEUTICALS INC | 65,000 | $5.033M | 1.6% | $77.43 | — | COM | 032420101 |
| QURE | UNIQURE NV | 185,000 | $4.995M | 1.6% | $28.48 | 0.0% | SHS | N90064101 |
| — | ENDOCHOICE HLDGS INC | 300,000 | $4.905M | 1.6% | $16.35 | — | COM | 29272U103 |
| PTCT | PTC THERAPEUTICS INC | 100,000 | $4.813M | 1.6% | $45.25 | +28.9% | COM | 69366J200 |
| CLLS | CELLECTIS S A | 125,000 | $4.51M | 1.5% | $36.08 | — | SPONSORED ADS | 15117K103 |
| VNDA | VANDA PHARMACEUTICALS INC | 350,000 | $4.442M | 1.4% | $10.78 | 0.0% | COM | 921659108 |
| — | ZELTIQ AESTHETICS INC | 150,000 | $4.421M | 1.4% | $25.00 | — | COM | 98933Q108 |
| — | CYNAPSUS THERAPEUTICS INC | 262,696 | $4.279M | 1.4% | $16.29 | — | COM PAR NO PAR | 23257Y859 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 350,000 | $4.221M | 1.4% | $11.62 | 0.0% | COM CL A | 46333X108 |
| — | SAGE THERAPEUTICS INC | 57,500 | $4.198M | 1.4% | $50.23 | — | COM | 78667J108 |
| — | VITAE PHARMACEUTICALS INC | 289,200 | $4.164M | 1.3% | $11.71 | — | COM | 92847N103 |
| — | WRIGHT MED GROUP INC | 150,000 | $3.939M | 1.3% | $26.87 | — | COM | 98235T107 |
| — | ALCOBRA LTD | 600,000 | $3.924M | 1.3% | $5.63 | — | SHS | M2239P109 |
| — | SUNESIS PHARMACEUTICALS INC | 1,250,000 | $3.763M | 1.2% | $2.45 | — | COM NEW | 867328601 |
| — | GENOCEA BIOSCIENCES INC | 270,000 | $3.707M | 1.2% | $11.86 | — | COM | 372427104 |
| — | ASSEMBLY BIOSCIENCES INC | 175,000 | $3.371M | 1.1% | $13.08 | — | COM | 045396108 |
| ELV | ANTHEM INC | 20,000 | $3.283M | 1.1% | $137.52 | 0.0% | COM | 036752103 |
| — | ROCKWELL MED INC | 200,000 | $3.224M | 1.0% | — | — | Call | 774374102 |
| — | KEMPHARM INC | 175,000 | $3.215M | 1.0% | $18.37 | — | COM | 488445107 |
| — | LION BIOTECHNOLOGIES INC | 350,000 | $3.21M | 1.0% | $10.85 | — | COM | 53619R102 |
| — | THERAPEUTICSMD INC | 400,000 | $3.144M | 1.0% | $5.07 | — | COM | 88338N107 |
| — | AXOVANT SCIENCES LTD | 135,000 | $2.751M | 0.9% | $20.38 | — | COM | G0750W104 |
| — | FOAMIX PHARMACEUTICALS LTD | 250,000 | $2.563M | 0.8% | $10.25 | — | SHS | M46135105 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 150,000 | $2.436M | 0.8% | $46.08 | — | Call | 05337G107 |
| — | BIODELIVERY SCIENCES INTL IN | 300,000 | $2.388M | 0.8% | $7.96 | — | COM | 09060J106 |
| — | SAGE THERAPEUTICS INC | 31,700 | $2.314M | 0.7% | $50.23 | — | Call | 78667J108 |
| PBYI | PUMA BIOTECHNOLOGY INC | 17,500 | $2.043M | 0.7% | $214.23 | -15.5% | COM | 74587V107 |
| — | TONIX PHARMACEUTICALS HLDG C | 202,500 | $1.816M | 0.6% | $8.97 | — | COM NEW | 890260201 |
| — | RADIUS HEALTH INC | 25,000 | $1.693M | 0.5% | $41.16 | — | COM NEW | 750469207 |
| — | VERSARTIS INC | 100,000 | $1.522M | 0.5% | $15.22 | — | COM | 92529L102 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 76,850 | $1.409M | 0.5% | $18.33 | — | SPONDS ADR | 00653A107 |
| ASND | ASCENDIS PHARMA A S | 63,739 | $1.127M | 0.4% | $17.68 | — | SPONDSORED ADR | 04351P101 |
| — | UNILIFE CORP NEW | 450,000 | $968K | 0.3% | $4.01 | — | COM | 90478E103 |
| VCYT | VERACYTE INC | 78,386 | $873K | 0.3% | $9.84 | 0.0% | COM | 92337F107 |
| — | BIODELIVERY SCIENCES INTL IN | 106,200 | $845K | 0.3% | $7.96 | — | Call | 09060J106 |
| — | NIVALIS THERAPEUTICS INC | 50,000 | $758K | 0.2% | $15.16 | — | COM | 65481J109 |
| BCRX | BIOCRYST PHARMACEUTICALS | 45,000 | $672K | 0.2% | $11.37 | 0.0% | COM | 09058V103 |
| — | KINDRED BIOSCIENCES INC | 93,500 | $638K | 0.2% | $7.14 | — | COM | 494577109 |
| — | BIOLASE INC | 300,000 | $522K | 0.2% | $2.41 | — | COM | 090911108 |
| — | XOMA CORP DEL | 125,000 | $485K | 0.2% | $3.74 | — | COM | 98419J107 |
| — | OCERA THERAPEUTICS INC | 125,000 | $475K | 0.2% | $10.04 | — | COM | 67552A108 |
| GKOS | GLAUKOS CORP | 15,000 | $435K | 0.1% | $29.05 | 0.0% | COM | 377322102 |
| XENE | XENON PHARMACEUTICALS INC | 37,500 | $432K | 0.1% | $13.82 | 0.0% | COM | 98420N105 |
| — | NEOTHETICS INC | 43,000 | $387K | 0.1% | $9.00 | — | COM | 64066G101 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 15,000 | $244K | 0.1% | $46.08 | — | COM | 05337G107 |